Modalis Therapeutics (4883.TSE) Q1 2026 Earnings

12FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-10.51
-8.29
-6.07
-3.85

Details

Expected EPS
N/A
Actual EPS
-3.8514675897000004
Surprise EPS
-3.85
Surprise Percent
+∞%

Description

Modalis Therapeutics (4883.TSE) has reported earnings of -3.8514675897000004 per share for Q1 2026.

0 Comments

Share your thoughts